• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER; NRY Back to Search Results
Catalog Number RED72KIT
Medical Device Problem Codes Break (1069); Unraveled Material (1664); Physical Resistance/Sticking (4012)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/01/2023
Type of Reportable Event Malfunction
Event or Problem Description
The patient was undergoing a thrombectomy procedure in the internal carotid artery (ica) using a penumbra system red 72 reperfusion catheter (red72), a benchmark bmx96 access system (bmx96), a non-penumbra microcatheter, and a guidewire.During the procedure, the physician placed the bmx96 into the patient.While advancing the red72 over the microcatheter and guidewire through the bmx96, the physician experienced resistance.The red72 would not advance past the carotid siphon.It was reported that the physician thought that the red72 reached the face of the clot.The physician then removed the microcatheter and guidewire and initiated aspiration.However, it was noticed that no thrombus was being removed and after two minutes under aspiration the physician began to retract the red72.Subsequently, resistance was encountered, but then the physician felt a reduction in resistance and was able to remove the red72.After removal, the physician noticed that the distal end of the red72 was unraveled but remained intact.Therefore, the red72 was not used for the remainder of the procedure.The procedure was completed using a penumbra system red 68 reperfusion catheter (red68), the same bmx96, and the same microcatheter.There was no report of an adverse effect to the patient.
 
Additional Manufacturer Narrative
The product was not returned for evaluation.Without the return of the device, the root cause of the problem cannot be determined.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER
Common Device Name
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key16624823
Report Number3005168196-2023-00141
Device Sequence Number17710221
Product Code NRY
UDI-Device Identifier00815948023932
UDI-Public815948023932
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K211654
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/27/2023
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/25/2025
Device Catalogue NumberRED72KIT
Device Lot NumberH00000780
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/01/2023
Initial Report FDA Received Date03/27/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured04/07/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age53 YR
Patient SexFemale
Date Report Sent to FDA01/01/2005
-
-